Gene therapy as an adjuvant treatment for malignant gliomas: from bench to bedside (Q34980337)

5 August 2017

1 reference

title

Gene therapy as an adjuvant treatment for malignant gliomas: from bench to bedside (English)

1 reference

5 August 2017

0 references

Isabelle M Germano

1

1 reference

5 August 2017

Emanuela Binello

series ordinal

2

1 reference

5 August 2017

publication date

9 May 2009

1 reference

Journal of Neuro-Oncology

5 August 2017

published in

1 reference

5 August 2017

volume

93

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

79-87

1 reference

Gene delivery by embryonic stem cells for malignant glioma therapy: hype or hope?

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9869-5

Embryonic stem cell-derived astrocytes: a novel gene therapy vector for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9869-5

Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9869-5

AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9869-5

Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9869-5

Ultrasound-enhanced chemotherapy and gene delivery for glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9869-5

Is mda-7/IL-24 a "magic bullet" for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9869-5

TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma

21 January 2018

1 reference

12 December 2020

Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy

1 reference

12 December 2020

In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma

1 reference

12 December 2020

Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

1 reference

12 December 2020

The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

1 reference

12 December 2020

Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma

1 reference

12 December 2020

High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunity.

1 reference

12 December 2020

Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas

1 reference

12 December 2020

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors

1 reference

12 December 2020

Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.

1 reference

12 December 2020

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses

1 reference

12 December 2020

Embryonic stem cell-derived astrocytes expressing drug-inducible transgenes: differentiation and transplantion into the mouse brain

1 reference

12 December 2020

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy

1 reference

12 December 2020

Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.

1 reference

12 December 2020

Delivery vehicles for small interfering RNA in vivo

1 reference

12 December 2020

Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats

1 reference

12 December 2020

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

1 reference

12 December 2020

Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector

1 reference

12 December 2020

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

1 reference

12 December 2020

Nanotechnology: a focus on nanoparticles as a drug delivery system

1 reference

12 December 2020

Cancer statistics, 2003.

1 reference

12 December 2020

Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.

1 reference

12 December 2020

Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression.

1 reference

12 December 2020

Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy

1 reference

12 December 2020

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

1 reference

12 December 2020

Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors

1 reference

12 December 2020

Adenovirus-mediated transfer of caspase-8 augments cell death in gliomas: implication for gene therapy

1 reference

12 December 2020

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

1 reference

12 December 2020

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

1 reference

12 December 2020

Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results

1 reference

12 December 2020

Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.

1 reference

12 December 2020

Neural precursor cells as carriers for a gene therapeutical approach in tumor therapy.

1 reference

12 December 2020

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

1 reference

12 December 2020

Progress and prospects: gene therapy clinical trials (part 1).

1 reference

12 December 2020

Endothelial progenitor cells' "homing" specificity to brain tumors

1 reference

12 December 2020

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

1 reference

12 December 2020

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias

1 reference

12 December 2020

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial

1 reference

12 December 2020

Virus-mediated killing of cells that lack p53 activity

1 reference

12 December 2020

Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line.

1 reference

12 December 2020

Advances in gene therapy for movement disorders.

1 reference

12 December 2020

Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.

1 reference

12 December 2020

Molecular therapies for malignant glioma

1 reference

12 December 2020

Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir

1 reference

12 December 2020

Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand

1 reference

12 December 2020

Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes

1 reference

12 December 2020

In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses

1 reference

12 December 2020

Evaluation of factors predicting accurate resection of high-grade gliomas by using frameless image-guided stereotactic guidance

1 reference

12 December 2020

The ADA human gene therapy clinical protocol

1 reference

12 December 2020

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

12 December 2020

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

1 reference

12 December 2020

Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy

1 reference

12 December 2020

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

1 reference

12 December 2020

Brain tumor survival: results from the National Cancer Data Base

1 reference

12 December 2020

Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans

1 reference

12 December 2020

Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer

1 reference

12 December 2020

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

1 reference

12 December 2020

A phase I trial of Ad.hIFN-beta gene therapy for glioma

1 reference

12 December 2020

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

1 reference

12 December 2020

Preventing growth of brain tumors by creating a zone of resistance

1 reference

12 December 2020

Genetic modification of neural stem cells

1 reference

12 December 2020

Glioma immunotherapy by IL-21 gene-modified cells or by recombinant IL-21 involves antibody responses.

1 reference

12 December 2020

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

1 reference

12 December 2020

Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.

1 reference

12 December 2020

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

1 reference

12 December 2020

Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector

1 reference

12 December 2020

Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector

1 reference

12 December 2020

Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study

1 reference

12 December 2020

Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas.

1 reference

12 December 2020

A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma

1 reference

12 December 2020

Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand

1 reference

12 December 2020

In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas

1 reference

12 December 2020

Genetic strategies for brain tumor therapy

1 reference

12 December 2020

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

12 December 2020

Gene therapy: a primer for neurosurgeons

1 reference

12 December 2020

Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma

1 reference

12 December 2020

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas

1 reference

12 December 2020

10.1007/S11060-009-9869-5

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1014359181

0 references

1 reference